Evidence map›Paper›PMID 31158073›Full record

Trial reportEuropean urology oncology2018

Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial.

Martin Nyberg, Jonas Hugosson, Peter Wiklund, Daniel Sjoberg, Ulrica Wilderäng, Sigrid V Carlsson, Stefan Carlsson, Johan Stranne, Gunnar Steineck, Eva Haglind and 2 more

Open access · hybridAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in European urology oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Open vs. robotic prostatectomy using VersiusJournal of robotic surgery · 2026
    Observational
  8. Article
  9. Review
  10. Article
  11. Robot-AssistedThe world journal of men's health · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Advances in Techniques in Radical Prostatectomy.Medicina (Kaunas, Lithuania) · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Martin NybergDepartment of Urology, Skåne University Hospital, Malmö, Sweden; Department of Translational Medicine, Division of Urological Cancers, Faculty of Medicine, Lund University, Sweden.
Jonas HugossonInstitute of Clinical Sciences, Department of Urology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Peter WiklundDepartment of Molecular Medicine and Surgery, Section of Urology, Karolinska Institute, Stockholm, Sweden.
Daniel SjobergDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ulrica WilderängDepartment of Oncology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Sigrid V CarlssonDepartment of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Stefan CarlssonDepartment of Molecular Medicine and Surgery, Section of Urology, Karolinska Institute, Stockholm, Sweden.
Johan StranneInstitute of Clinical Sciences, Department of Urology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Gunnar SteineckDepartment of Oncology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Division of Clinical Cancer Epidemiology, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
Eva HaglindDepartment of Surgery, Institute of Clinical Sciences, Scandinavian Surgical Outcomes Research Group, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
Anders BjartellDepartment of Urology, Skåne University Hospital, Malmö, Sweden; Department of Translational Medicine, Division of Urological Cancers, Faculty of Medicine, Lund University, Sweden. Electronic address: anders.bjartell@med.lu.se.
LAPPRO group
University of Gothenburg · SEKarolinska Institutet · SELund University · SEMemorial Sloan Kettering Cancer Center · USSahlgrenska University Hospital · SESkåne University Hospital · SE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
SPORE In Prostate CancerP50CA092629 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI JAMES A EASTHAM · 2001 to 2026
$63.0M
Modeling to Improve Prostate Cancer Outcomes Across Diverse PopulationsU01CA199338 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DE KONING, HARRY J, ETZIONI, RUTH D · 2015 to 2019
$5.2M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA092629NCI NIH HHS U01 CA199338
6 · The paper itself

Abstract

backgroundThe adoption of robot-assisted laparoscopic radical prostatectomy (RALP) has increased rapidly, despite lack of conclusive evidence of its superiority regarding long-term outcomes over open retropubic RP (RRP). In 2015, we reported on 12-mo follow-up from the LAPPRO trial showing a moderate advantage of RALP regarding erectile dysfunction. No significant differences were seen for urinary incontinence or surgical margin status.

objectiveTo present patient-reported functional outcomes and recurrent and residual disease at 24-mo follow-up from the prospective multicenter LAPPRO trial. DESIGN, SETTING, AND

participantsA total of 4003 patients with clinically localized prostate cancer were recruited from 14 Swedish centers, seven performing RALP and seven RRP. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Data were only analyzed for patients operated on by surgeons with >100 prior RPs. Adjusted odds ratios (AORs) were calculated using logistic regression, with adjustment for differences in patient mix. RESULTS AND LIMITATIONS: At 24 mo, there was a significant difference in erectile dysfunction in favor of RALP (68% vs 74%; AOR 0.72, 95% confidence interval [CI] 0.57-0.91; p=0.006). No significant difference was observed for incontinence (19% vs 16%; AOR 1.29, 95% CI 1.00-1.67; p=0.053) or recurrent or residual disease (13% vs 13%; AOR 0.79, 95% CI 0.59-1.07; p=0.13). We did not adjust for individual surgeon volume and experience, which is a potential limitation.

conclusionsExtended follow-up corroborated our previous report at 12 mo of a persistent RALP benefit regarding potency. PATIENT SUMMARY: LAPPRO is a Swedish trial comparing two different prostate cancer surgical techniques (robotic compared to open). At 24-mo follow-up after surgery there was a moderate advantage for the robotic technique regarding erectile dysfunction (potency), while there was a small but not significant difference in urinary leakage in favor of open surgery. We did not find any difference regarding cancer relapse.

Indexed as

ProstatectomyRobotic Surgical ProceduresAgedErectile DysfunctionFollow-Up StudiesHumansLaparoscopyMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm, ResidualPatient Reported Outcome MeasuresPostoperative ComplicationsProstatic NeoplasmsSwedenTreatment OutcomeBiochemical recurrenceErectile dysfunctionOpen radical prostatectomyProstate cancerRobot-assisted laparoscopic radical prostatectomyUrinary incontinence

Identifiers

PMID31158073
PMCPMC7061692
OpenAlexW2804793074

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.